The role of immune-checkpoints inhibitors for advanced colorectal cancer treatment


E-session 519000

Expert
Ramon Andrade Bezerra de Mello'
Substantive Consultant Medical Oncologist
Oxford Cancer Centre, Oxford University Hospitals NHS Foundation Trust
Oxford, United Kingdom
Discussant
Antonia Digklia'
CHUV
Lausanne, Switzerland

This e-Session is part of the following pathway(s):
7
25
Mar 2020